Epidemiological associations between on and cardiovascular disease and diabetes

被引:89
|
作者
Basuli, Debargha [1 ]
Stevens, Richard G. [2 ]
Torti, Frank M. [1 ]
Torti, Suzy V. [1 ]
机构
[1] Univ Connecticut, Ctr Hlth, Farmington, CT 06030 USA
[2] Univ Connecticut, Ctr Hlth, Dept Community Med & Hlth Care, Div Epidemiol & Biostat, Farmington, CT 06030 USA
关键词
iron; cardiovascular disease; diabetes mellitus; metabolic syndrome; epidemiologic studies; NONALCOHOLIC FATTY LIVER; BODY IRON STORES; CORONARY-HEART-DISEASE; SERUM FERRITIN LEVELS; C-REACTIVE PROTEIN; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPOSE-TISSUE; RISK-FACTORS; INCREASED SUSCEPTIBILITY;
D O I
10.3389/fphar.2014.00117
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Disruptions in iron homeostasis are linked to a broad spectrum of chronic conditions including cardiovascular, malignant, metabolic, and neurodegenerative disease. Evidence supporting this contention derives from a variety of analytical approaches, ranging from molecular to population-based studies. This review focuses on key epidemiological studies that assess the relationship between body iron status and chronic diseases, with particular emphasis on atherosclerosis,metabolic syndrome and diabetes. Multiple surrogates have been used to measure body iron status, including serum ferritin, transferrin saturation, serum iron, and dietary iron intake. The lack of a uniform and standardized means of assessing body iron status has limited the precision of epidemiological associations. Intervention studies using depletion of iron to alter risk have been conducted. Genetic and molecular techniques have helped to explicate the biochemistry of iron metabolism at the molecular level. Plausible explanations for how iron contributes to the pathogenesis of these chronic diseases are beginning to be elucidated. Most evidence supports the hypothesis that excess iron contributes to chronic disease by fostering excess production of free radicals. Overall, epidemiological studies, reinforced by basic science experiments, provide a strong line of evidence supporting the association between iron and elevated risk of cardiovascular disease and diabetes. In this narrative review we attempt to condense the information from existing literature on this topic.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Insulin Resistance: the Link Between Obesity and Cardiovascular Disease
    Reaven, Gerald M.
    MEDICAL CLINICS OF NORTH AMERICA, 2011, 95 (05) : 875 - +
  • [32] Is Insulin Resistance a Feature of or a Primary Risk Factor for Cardiovascular Disease?
    Laakso, Markku
    CURRENT DIABETES REPORTS, 2015, 15 (12) : 1 - 9
  • [33] Preventing Cardiovascular Disease in Patients with Diabetes: Use of Aspirin for Primary Prevention
    Desai, Dhaval
    Ahmed, Haitham M.
    Michos, Erin D.
    CURRENT CARDIOLOGY REPORTS, 2015, 17 (03) : 1 - 9
  • [34] Global cardiovascular disease risk assessment in United States adults with diabetes
    Wong, Nathan D.
    Glovaci, Diana
    Wong, Kalina
    Malik, Shaista
    Franklin, Stanley S.
    Wygant, Gail
    Iloeje, Uchenna
    DIABETES & VASCULAR DISEASE RESEARCH, 2012, 9 (02): : 146 - 152
  • [35] Early Insulin Treatment to Prevent Cardiovascular Disease in Prediabetes and Overt Diabetes
    Roman, G.
    Hancu, N.
    HORMONE AND METABOLIC RESEARCH, 2009, 41 (02) : 116 - 122
  • [36] Alcohol Consumption, Diabetes Risk, and Cardiovascular Disease Within Diabetes
    Polsky, Sarit
    Akturk, Halis K.
    CURRENT DIABETES REPORTS, 2017, 17 (12)
  • [37] Cardiovascular disease in diabetes
    Zhang, P. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2014, 18 (15) : 2205 - 2214
  • [38] Cardiovascular Disease in Type 2 Diabetes From Population to Man to Mechanisms - The Kelly West Award Lecture 2008
    Laakso, Markku
    DIABETES CARE, 2010, 33 (02) : 442 - 449
  • [39] Late Cardiovascular Consequences of Gestational Diabetes Mellitus
    Bentley-Lewis, Rhonda
    SEMINARS IN REPRODUCTIVE MEDICINE, 2009, 27 (04) : 322 - 329
  • [40] Erectile dysfunction as a marker of silent cardiovascular disease in type-2 diabetic patients in Spain. The DIVA (Diabetes and VAscular disease) study
    Ramon Gonzalez-Juanatey, Jose
    Alegria Ezquerra, Eduardo
    Gomis Barbera, Ramon
    Salvador Taboada, Maria Jesus
    Grigorian Shamagian, Lilian
    Casasnovas Lenguas, Jose Antonio
    Lopez Garcia-Aranda, Victor
    Acosta Delgado, Domingo
    Salvador Rodriguez, Javier
    Hernandez Mijares, Antonio
    Matali Gilarranz, Arantxa
    MEDICINA CLINICA, 2009, 132 (08): : 291 - 297